Category: Oncology/Hematology
Europe Oncology/Hematology
-
Herceptin Biosimilar Market, by Indication (Breast Cancer, Gastric Cancer, and Others), by Distribution Channel (Hospital, Oncology Centers, and Others) and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) - Size, Sh
... Share, Outlook, and Opportunity Analysis, 2022 - 2028 Trastuzumab, sold under the brand Herceptin, is a monoclonal antibody used for the treatment of breast cancer and gastric cancer. Herceptin is mainly used to treat patients ... Read More
-
Cervical Cancer Diagnostic Tests Market, By Test Type (Pap Smear Test, Colposcopy Test, ECC Test, and HPV Test), By Age Group (Age 20 – 40 and Age Above 40), and By Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) - S
... America, Europe, Asia Pacific, Middle East, and Africa) - Size, Share, Outlook, and Opportunity Analysis, 2022 - 2028 Cervical cancer occurs in the cells of the cervix. Pap smear, colposcopy, and ECC procedures are performed ... Read More
-
DNA/Gene Microarray Market, By Type (oDNA, cDNA), By Application (Genomics, Proteomics, Agricultural biology, Environment, Drug R&D, Gene expression and SNP analysis, Cancer/oncology, Others), and By Region (North America, Latin America, Europe, Asia Paci
... & Africa) - Size, Share, Outlook, and Opportunity Analysis, 2022 - 2028 DNA Chips, Biochips or DNA microarrays consists of a microscope slide made materials such as glass, silicon chips, and nylon membrane, which is ... Read More
-
Medical Tourism Market, by Treatment Type (Cardiovascular, Orthopedic, Neurological, Cancer, Fertility and Others), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) - Size, Share, Outlook, and Opportunity Analysi
... - 2028 Medical tourism refers to people traveling abroad to obtain medical treatment. Factors such as high cost of healthcare and long waiting time for certain procedures have increased the popularity of medical tourism. Domestic ... Read More
-
Adoptive Cell Therapy Market, by Type (CAR-T, TCR-T, NK, and TIL), By Application (Lymphoma, Leukemia, and Others), by End User (Hospitals and Cancer Treatment Centers), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and A
... Middle East, and Africa) - Size, Share, Outlook, and Opportunity Analysis, 2022 - 2030 Adoptive cell therapy (ACT) is a type of immunotherapy in which T cells (a type of immune cell) are given to ... Read More
-
2022-2026 Poland Tumor Markers Testing Market High-Growth Opportunities for Cancer Diagnostic Tests and AnalyzersSupplier Shares and Strategies, Volume and Sales Segment Forecasts, Latest Technologies and Instrumentation Pipeline, Emerging Opportunities for Suppliers
... LeadingMarketResearch.com provides a strategic analysis of the major business opportunities emerging in the cancer diagnostics market during the next five years. The report examines emerging trends in the cancer diagnostics market; reviews current and emerging ... Read More
-
2022-2026 Estonia Tumor Markers Testing Market High-Growth Opportunities for Cancer Diagnostic Tests and AnalyzersSupplier Shares and Strategies, Volume and Sales Segment Forecasts, Latest Technologies and Instrumentation Pipeline, Emerging Opportunities for Suppliers
... LeadingMarketResearch.com provides a strategic analysis of the major business opportunities emerging in the cancer diagnostics market during the next five years. The report examines emerging trends in the cancer diagnostics market; reviews current and emerging ... Read More
-
2022-2026 Ireland Tumor Markers Testing Market High-Growth Opportunities for Cancer Diagnostic Tests and AnalyzersSupplier Shares and Strategies, Volume and Sales Segment Forecasts, Latest Technologies and Instrumentation Pipeline, Emerging Opportunities for Suppliers
... LeadingMarketResearch.com provides a strategic analysis of the major business opportunities emerging in the cancer diagnostics market during the next five years. The report examines emerging trends in the cancer diagnostics market; reviews current and emerging ... Read More
-
2022-2026 Ukraine Tumor Markers Testing Market High-Growth Opportunities for Cancer Diagnostic Tests and AnalyzersSupplier Shares and Strategies, Volume and Sales Segment Forecasts, Latest Technologies and Instrumentation Pipeline, Emerging Opportunities for Suppliers
... LeadingMarketResearch.com provides a strategic analysis of the major business opportunities emerging in the cancer diagnostics market during the next five years. The report examines emerging trends in the cancer diagnostics market; reviews current and emerging ... Read More
-
Car T Cell Therapy Market, by Type (Abecma, Breyanzi, Kymriah, Tecartus, and Yescarta), by Application (Cancer, Lymphoma, and Others), by End Users (Hospitals, Specialty Clinics, and Others), and by Region (North America, Latin America, Europe, Asia Pacif
... Asia Pacific, Middle East, and Africa) - Size, Share, Outlook, and Opportunity Analysis, 2022 - 2028 Chimeric antigen receptor (CAR) T-cell therapy is a type of immunotherapy that modifies a patient’s immune system so it ... Read More
-
Europe Pharmacogenomics Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Technology (PCR, Sequencing, Microarray, Gel Electrophoresis, Mass Spectrometry, and Others), Application (Drug Discovery, Oncology, Neurology and Psychiatry, Pain Management, Cardiovascular Diseases, and Others), and End User (Hospitals and Clinics, Biopharmaceutical Companies, CROs and CDMOs, and Others)
... Others), and End User (Hospitals and Clinics, Biopharmaceutical Companies, CROs and CDMOs, and Others) The Europe pharmacogenomics market is expected to reach US$ 3,874.31 million by 2028 from US$ 1,962.48 million in 2021. It is ... Read More
-
Europe Oncology Market Databank
... segment is expected to be the highest contributor to this market, with $138,915.1 Million in 2020, and is anticipated to reach $199,183.8 Million by 2029, registering a CAGR of 4.13%. Cancer diagnostics segment is anticipated ... Read More
-
Nucleic Acid Testing (NAT) Market: US, Europe, Japan-Supplier Sales and Shares by Test, Volume and Sales Forecasts for 100 Infectious, Cancer and Genetic Diseases, Forensic and Paternity Testing/HLA Typing-Technological Breakthroughs, Emerging Tests, Competitive Analysis
... new seven-country study from LeadingMarketResearch is designed to help current suppliers and potential market entrants identify and evaluate major business opportunities emerging in the molecular diagnostics market during the next five years. Highlights Business and ... Read More
-
France Molecular Genetic, Cancer, Forensic and Paternity Testing Market: Supplier Sales and Shares, Volume and Sales Segment Forecasts, Competitive Analysis, Emerging Technologies, Latest Instrumentation, Growth Opportunities
... current suppliers and potential market entrants identify and evaluate emerging opportunities for molecular diagnostic technologies and products in testing for genetic diseases, cancer, as well as forensic and paternity/HLA typing applications during the next five ... Read More
-
Germany Molecular Genetic, Cancer, Forensic and Paternity Testing Market: Supplier Sales and Shares, Volume and Sales Segment Forecasts, Competitive Analysis, Emerging Technologies, Latest Instrumentation, Growth Opportunities
... current suppliers and potential market entrants identify and evaluate emerging opportunities for molecular diagnostic technologies and products in testing for genetic diseases, cancer, as well as forensic and paternity/HLA typing applications during the next five ... Read More
-
Italy Molecular Genetic, Cancer, Forensic and Paternity Testing Market: Supplier Sales and Shares, Volume and Sales Segment Forecasts, Competitive Analysis, Emerging Technologies, Latest Instrumentation, Growth Opportunities
... current suppliers and potential market entrants identify and evaluate emerging opportunities for molecular diagnostic technologies and products in testing for genetic diseases, cancer, as well as forensic and paternity/HLA typing applications during the next five ... Read More
-
Hematology and Flow Cytometry: US, Europe, Japan-A Market Facing Regulatory and Competitive Challenges-Supplier Shares and Segment Forecasts by Test-Technological Breakthroughs, Emerging Tests, Competitive Analysis
... potential market entrants identify and evaluate business opportunities emerging in the global hematology and flow cytometry markets during the next five years. The report explores business and technological trends in the US, Europe (France, Germany, ... Read More
-
Europe Next-generation Antibody Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Therapeutic Area (Oncology, and Autoimmune or Inflammatory) and Technology (Antibody-drug conjugates, Bispecific antibodies, Fc engineered antibodies, Antibody fragments & antibody-like proteins, and Biosimilar antibody products)
... and Biosimilar antibody products) The Europe next-generation antibody market is expected to reach US$ 3,162.30 million by 2028 from US$ 1,455.32 million in 2021. It is estimated to grow at a CAGR of 11.7% from ... Read More
-
2022-2026 Succeeding in the Global Hematology and Flow Cytometry Market: US, Europe, Japan - Analyzer and Consumable Supplier Shares, Segment Forecasts by Test and Country, Competitive Intelligence, Emerging Technologies, Latest Instrumentation, Opportunities for Suppliers
... This comprehensive seven-country report is designed to help current suppliers and potential market entrants identify and evaluate business opportunities emerging in the global hematology and flow cytometry markets during the next five years. The report ... Read More
-
2022-2026 Succeeding in the Italy Hematology and Flow Cytometry Market: Analyzer and Consumable Supplier Shares, Segment Forecasts by Test, Competitive Intelligence, Emerging Technologies, Instrumentation and Opportunities for Suppliers
... help current suppliers and potential market entrants identify and evaluate business opportunities emerging in Italian hematology and flow cytometry markets during the next five years. The report explores business and technological trends in the Italian ... Read More
-
2022-2026 Succeeding in the France Hematology and Flow Cytometry Market: Analyzer and Consumable Supplier Shares, Segment Forecasts by Test, Competitive Intelligence, Emerging Technologies, Instrumentation and Opportunities for Suppliers
... help current suppliers and potential market entrants identify and evaluate business opportunities emerging in French hematology and flow cytometry markets during the next five years. The report explores business and technological trends in the French ... Read More
-
2022-2026 Succeeding in the UK Hematology and Flow Cytometry Market: Analyzer and Consumable Supplier Shares, Segment Forecasts by Test, Competitive Intelligence, Emerging Technologies, Instrumentation and Opportunities for Suppliers
... help current suppliers and potential market entrants identify and evaluate business opportunities emerging in UK hematology and flow cytometry markets during the next five years. The report explores business and technological trends in the UK ... Read More
-
Adoptive Cell Therapy Market, by Type (CAR-T, TCR-T, NK, and TIL), By Application (Lymphoma, Leukemia, and Others), by End User (Hospitals and Cancer Treatment Centers), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) - Size, Share, Outlook, and Opportunity Analysis, 2022 - 2030
... Middle East, and Africa) - Size, Share, Outlook, and Opportunity Analysis, 2022 - 2030 Adoptive cell therapy (ACT) is a type of immunotherapy in which T cells (a type of immune cell) are given to ... Read More
-
Europe Cervical Cancer Diagnostic Testing Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Type (PAP Testing, HPV Testing, Colposcopy, Cervical Biopsies, Cystoscopy, and Others) and Service Provider (Diagnostics and Research Laboratories, Hospitals and Clinics, Specialty Clinics, and Home Care Services)
... and Clinics, Specialty Clinics, and Home Care Services) The Europe cervical cancer diagnostic testing market is expected to grow from US$ 1,368.86 million in 2021 to US$ 1,881.38 million by 2028. It is estimated to ... Read More
-
Cancer Therapies Market in Europe 2022-2026
... the forecast period. Our report on the cancer therapies market in Europe provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors. The ... Read More
Research Assistance
